title: 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents.
authors.affiliation: Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709, USA. henkebr@glaxo.com
authors.forename: B R
authors.initials: BR
authors.lastname: Henke
authors.forename: T M
authors.initials: TM
authors.lastname: Willson
authors.forename: E E
authors.initials: EE
authors.lastname: Sugg
authors.forename: D K
authors.initials: DK
authors.lastname: Croom
authors.forename: R W
authors.initials: RW
authors.lastname: Dougherty
authors.forename: K L
authors.initials: KL
authors.lastname: Queen
authors.forename: L S
authors.initials: LS
authors.lastname: Birkemo
authors.forename: G N
authors.initials: GN
authors.lastname: Ervin
authors.forename: M K
authors.initials: MK
authors.lastname: Grizzle
authors.forename: M F
authors.initials: MF
authors.lastname: Johnson
authors.forename: M K
authors.initials: MK
authors.lastname: James
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001569:Benzodiazepines / Q000737:chemistry / Q000494:pharmacology*; D001665:Binding Sites; D016466:CHO Cells; D002766:Cholecystokinin / Q000819:agonists*; D006224:Cricetinae; D005704:Gallbladder / Q000187:drug effects; D006168:Guinea Pigs; D006801:Humans; D051379:Mice; D012528:Satiety Response / Q000187:drug effects*; D013329:Structure-Activity Relationship
chemical_list: D001569:Benzodiazepines; D002766:Cholecystokinin